Ligand validation:6NHP

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6NHP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6NHP_NAG_E_506	54%	37%	0.175	0.941	0.85	1.58	-	5	0	0	100%	0.9333
6NHP_NAG_E_501	33%	63%	0.215	0.895	0.46	0.93	-	1	0	0	100%	0.9333
6NHP_NAG_A_404	31%	32%	0.196	0.866	0.9	1.77	-	3	0	0	100%	0.9333
6NHP_NAG_C_501	20%	31%	0.198	0.799	0.68	2.01	-	1	0	0	100%	0.9333
6NHP_NAG_E_507	13%	41%	0.186	0.727	0.84	1.43	-	3	0	0	100%	0.9333
6NHP_NAG_C_502	7%	24%	0.232	0.686	0.83	2.27	-	4	0	0	100%	0.9333
6NHP_NAG_D_201	4%	31%	0.305	0.685	0.8	1.93	1	4	0	0	100%	0.9333
5K9Q_NAG_F_201	94%	88%	0.076	0.974	0.2	0.47	-	-	0	0	100%	0.9333
4O58_NAG_A_503	68%	33%	0.148	0.96	0.57	2.02	-	3	0	0	100%	0.9333
1HGE_NAG_A_334	68%	50%	0.095	0.905	0.76	1.17	-	2	0	0	100%	0.9333
6NHR_NAG_E_506	65%	54%	0.128	0.928	0.49	1.25	-	2	0	0	100%	0.9333
5KAN_NAG_C_401	62%	86%	0.131	0.922	0.2	0.5	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3CQL_NAG_B_244	100%	68%	0.029	0.987	0.42	0.8	-	-	0	0	100%	1
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.